Epithelial regeneration is critical for barrier maintenance and organ function after intestinal injury. The intestinal stem cell (ISC) niche provides Wnt, Notch and epidermal growth factor (EGF) signals supporting Lgr5 + crypt base columnar ISCs for normal epithelial maintenance 1,2 . However, little is known about the regulation of the ISC compartment after tissue damage. Using ex vivo organoid cultures, here we show that innate lymphoid cells (ILCs), potent producers of interleukin-22 (IL-22) after intestinal injury 3,4 , increase the growth of mouse small intestine organoids in an IL-22-dependent fashion. Recombinant IL-22 directly targeted ISCs, augmenting the growth of both mouse and human intestinal organoids, increasing proliferation and promoting ISC expansion. IL-22 induced STAT3 phosphorylation in Lgr5 + ISCs, and STAT3 was crucial for both organoid formation and IL-22mediated regeneration. Treatment with IL-22 in vivo after mouse allogeneic bone marrow transplantation enhanced the recovery of ISCs, increased epithelial regeneration and reduced intestinal pathology and mortality from graft-versus-host disease. ATOH1deficient organoid culture demonstrated that IL-22 induced epithelial regeneration independently of the Paneth cell niche. Our findings reveal a fundamental mechanism by which the immune system is able to support the intestinal epithelium, activating ISCs to promote regeneration.
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for SLIT2 or ROBO1, although they can regulate ISC recovery from damage induced by chemotherapy and radiation 11 (Extended Data Fig. 1h ). Consistently, there was also no increase in Wnt or Notch pathway gene expression in large intestine organoids (Extended Data Fig. 1i ). However, culture with IL-22 increased SI organoid mRNA levels of the innate antimicrobial molecules Reg3b and Reg3g (Extended Data Fig. 1j ), the expression of which is dependent on STAT3 signalling 12 .
Little is known about JAK/STAT signalling within ISCs, although it has been reported that STAT3 may be important for ISC maintenance 13 . We evaluated STAT3 signalling in SI organoids and found that IL-22 increased the phosphorylation of STAT3 Tyr705 (Extended Data Fig. 2a ). Furthermore, treatment with the STAT3 inhibitor Stattic significantly impaired SI organoid growth ( Fig. 2a and Extended Data Fig. 2b ). However, IL-22 can also promote epithelial STAT1 signalling 14 , which Stattic has inhibitory activity against 15 . Indeed, organoid STAT3 and STAT1 were both phosphorylated in response to IL-22, and inhibited by Stattic ( Fig. 2b ). To determine their relative importance for IL-22-induced epithelial regeneration, we assessed the growth of organoids with genetic deletion of either Stat1 or Stat3. Despite the induction of phosphorylated (p) STAT1 by IL-22, SI crypts from Stat1 −/− mice demonstrated intact organoid growth and response to IL-22 ( Fig. 2c and Extended Data Fig. 2c ). As Stat3 −/− mice are not viable, we next cultured SI crypt cells from Stat3 fl/fl mice with adenoviral-Cre (adeno-Cre) to delete STAT3. Crypt cells from wildtype mice demonstrated intact organoid growth and IL-22 response despite in vitro infection with adeno-Cre ( Fig. 2d ). Additionally, uninfected Stat3 fl/fl crypt cells demonstrated normal organoid growth and response to IL-22 (Extended Data Fig. 2d, e ). However, crypt cells from Stat3 fl/fl mice failed to generate organoids after infection with adeno-Cre, and IL-22 failed to recover organoid growth or augment organoid size (Fig. 2d ).
Lgr5 + ISCs can generate all cell types of mature intestinal epithelium ex vivo and in vivo 1, 10 . To evaluate whether STAT3 was important for ISCs during tissue damage in vivo, we performed a gene set enrichment analysis (GSEA), assessing expression of a published Lgr5 + ISC gene signature (Gene Expression Omnibus (GEO) data set GSE33948) 16 in another data set of wild-type (Stat3 fl/fl ) versus epithelial STAT3-deficient (Stat3 fl/fl ;Villin-Cre) mice with dextran sulfate sodium (DSS) colitis (GSE15955) 12 . Expression of the Lgr5 + ISC gene signature was significantly reduced in STAT3-deficient mice with colitis ( Fig. 2e ). This was validated with a second independently established Lgr5 + ISC gene signature (GEO data set GSE23672) 16 , while no significant changes were seen with a negative-control Paneth cell gene signature (GEO data set GSE39915) 17 (Extended Data Fig. 2f, g) . Given the induction of pSTAT3 by IL-22 and the importance of STAT3 for ISC gene signature maintenance, we examined the effect of IL-22 during regeneration using purified ISCs. We isolated Lgr5-GFP SI ISCs by fluorescence-activated cell sorting (FACS) and cultured purified ISCs under standard conditions 10 with or without IL-22. IL-22 significantly increased the budding of early organoids after just 4 days ( Fig. 2f ). Furthermore, as with crypt-derived organoids, 1 ng ml −1 rmIL-22 augmented the size of organoids generated from purified ISCs without affecting the efficiency of organoid formation ( Fig. 2g and Extended Data Fig. 3a, b) .
Consistent with increased size, IL-22 enhanced 5-ethynyl-2′deoxyuridine (EdU) incorporation in SI organoids, demonstrating increased proliferation (Extended Data Fig. 4a, b ). Hoechst staining revealed an IL-22-dependent increase in G2/M populations after 2 days in culture (Fig. 2h) , and IL-22 treatment rapidly reduced expression of key cell cycle checkpoint molecules Cdkn1a and Cdkn2d in both small and large intestine organoids (Extended Data Fig. 4c, d) . Furthermore, IL-22 expanded Lgr5-GFP high ISCs in SI organoids ( Fig.  2i ) and increased expansion of SI organoids over several passages in culture ( Fig. 2j ). Next, we evaluated the ISC compartment after radiation injury. Pre-treatment with rmIL-22 increased the percentage of dissociated SI crypt cells that were viable in culture after ex vivo irradiation, as measured by MTT reduction (Extended Data Fig. 5a ). Consistent with this, IL-22 treatment increased the number of organoids that could grow from single cells 2 days after irradiation (Extended Data Fig. 5b ). This was more evident with increasing doses of irradiation, and protection was present even 7 days after irradiation (Extended Data Fig.  5c ). Accordingly, irradiation was found to increase the expression of Il22ra1 within intestinal crypts (Extended Data Fig. 5d ).
We next evaluated the effect of IL-22 in vivo after tissue damage using a clinically relevant mouse graft-versus-host disease (GVHD) model. T-cell-depleted (TCD) marrow from LP mice was transplanted with or without purified LP T cells into lethally irradiated C57BL/6 (B6) recipients (H-2 b into H-2 b ). Mice receiving allogeneic T cells for Figure 1 | IL-22 increases growth of intestinal organoids. a, Size of SI organoids cultured in ENR with IL-23-containing cytokine cocktail with/without LPLs; n = 62 (control), n = 72 (IL-23), n = 29 (wild-type (WT) LPLs), n = 34 (Il22 −/− LPLs) organoids per group; one of two experiments. b, Size of SI organoids cultured with/without ILC3s and anti-IL-22 neutralizing antibody; n = 47 (control), n = 55 (IL-23), n = 43 (ILC3s), n = 38 (anti-IL-22) organoids per group; one of two experiments. c, SI organoids cultured with/without rmIL-22 (5 ng ml −1 ) for 7 days. d, e, Size of organoids cultured with/without rmIL-22 for 7 days; n = 114 (control), n = 50 (0.1 ng ml −1 ), n = 47 (1 ng ml −1 ), n = 44 (5 ng ml −1 ) SI organoids per group (d); n = 115 (control), n = 61 (IL-22) large intestine (LI) organoids per group (e). f, New crypt formation (budding) of small (day 4) and large (day 7) intestine organoids; n = 6 mice per group. g, Size of human (Hu) SI organoids cultured with/without rhIL-22 (10 ng ml −1 ) in standard expansion medium; n = 38 (control), n = 67 (IL-22) organoids per group. Data are mean and s.e.m.; comparisons performed with t-tests (two groups) or analysis of variance (ANOVA) (multiple groups). NS, not significant; *P < 0.05, **P < 0.01, ***P < 0.001. Data combined from at least three independent experiments unless otherwise stated. 
GVHD induction were treated with 4 μg rmIL-22 or PBS daily via intraperitoneal (i.p.) injection starting 7 days after bone marrow transplantation (BMT). Treatment with IL-22 reduced histopathological evidence of GVHD in the small and large intestine ( Fig. 3a) , including a reduction in apoptosis within crypt epithelium (Extended Data Fig. 6a, b ). GVHD pathology was reduced despite an intact alloimmune response, as evidenced by similar T cell subset distribution, activation markers and gut homing molecules, as well as similar systemic and gastrointestinal expression of inflammatory cytokines (Extended Data Fig. 6c, d ). However, IL-22 treatment did increase SI expression of Reg3b and Reg3g mRNA ( Fig. 3b ). Consistent with previous findings 18 , we found that REG3β was primarily expressed by enterocytes in allogeneic BMT recipients, including after treatment with IL-22 (Extended Data Fig. 6e ).
GVHD is associated with a loss of both ISCs 19, 20 and niche-forming Paneth cells 21, 22 , and T-cell-replete BMT led to a significant loss of Lgr5-LacZ + SI ISCs 3 weeks after transplantation ( Fig. 3c ). However, IL-22 treatment increased the recovery of Lgr5 + ISCs (Fig. 3c ). This was associated with increased regeneration as evidenced by increased crypt height, including the transit-amplifying compartment (Fig. 3d ). Paneth cells support Lgr5 + ISCs through the delivery of Wnt, Notch ligand and EGF signals 2 . Additionally, IL-22 is thought to regulate Paneth cell production of innate antimicrobial molecules. We thus proposed that IL-22 could support ISC recovery after BMT by improving the function of the stem-cell niche. Consistent with previous clinical and experimental studies [21] [22] [23] , minor antigen-mismatched BMT led to a reduction in Paneth cells 3 weeks after transplantation ( Fig. 3e ). However, IL-22 administration did not increase recovery of Paneth cells ( Fig. 3e ), mRNA expression of Wnt3 or Egf (Extended Data Fig. 6f , g), or expression of Notch ligand target Hes1 (Extended Data Fig. 6h ). Furthermore, although stroma can support ISC Wnt signalling in vivo independently of Paneth cells 24 , we found no change in expression of stromal R-spondin-3 after IL-22 treatment post-BMT, and no change in expression of Wnt pathway genes regardless of the upstream source (Extended Data Fig. 6i -k). representative of three experiments. e, GSEA of ISC signature genes in wildtype versus Stat3 fl/fl ;Villin-Cre (Stat3 ΔIEC ) mice with DSS colitis; one analysis, nominal P value shown. f, g, Organoids from sorted SI Lgr5-GFP + ISCs cultured with/without rmIL-22 (1 ng ml −1 ). f, Organoid budding, percentage of total organoids per well (day 4, n = 11 wells per group). Representative images (right) of early budding indicate: early organoid without budding (asterisk); polarization before budding (arrowhead); budding at site of polarization (arrow). Scale bars, 50 μm. g, Organoid area (day 13), n = 54 organoids per group. h, Cell cycle FACS of SI organoid cells cultured with/without rmIL-22 (5 ng ml −1 ); n = 7 mice per group. i, FACS analysis of Lgr5-GFP high ISCs in organoids cultured with/without rmIL-22; n = 6 mice per group. j, Organoid expansion with serial passaging with/without rmIL-22 (1 ng ml −1 ); one of two experiments. Data are mean and s.e.m.; comparisons performed with t-tests (two groups) or ANOVA (multiple groups); *P < 0.05, **P < 0.01, ***P < 0.001. Data combined from at least two independent experiments unless otherwise stated. For western blot source data, see Supplementary Fig. 1 . 
Given that IL-22 treatment appeared to improve ISC numbers without improving niche function in BMT recipients, we sought to evaluate how IL-22 was targeting the ISC compartment. Consistent with the in vivo findings, IL-22 had no effect on Paneth cell frequency or α-defensin-1 expression within SI organoids cultured ex vivo (Extended Data Fig. 7a, b ). Immunofluorescent staining for IL-22Rα1 and the Paneth cell marker lysozyme using SI sections from Lgr5-GFP reporter mice indicated substantial IL-22R staining within crypts and enterocytes at the villous base, but not on lysozyme + Paneth cells ( Fig. 4a ). Using flow cytometry, there was also little evidence for expression of IL22Rα1 on Paneth cells at baseline or after radiation injury and no evidence of pSTAT3 in Paneth cells in response to IL-22 (Extended Data Fig. 7c-e ). By contrast, IL22Rα1 was identified in the transit-amplifying progenitor compartment and on Lgr5-GFP + ISCs (Fig. 4a ). IL-22R expression in Lgr5 + cells was confirmed by quantitative PCR (qPCR) after sorting for Lgr5-GFP + cells (Extended Data Fig. 8a, b ). Furthermore, SI crypt cells from Lgr5-GFP reporter mice demonstrated increased STAT3 Tyr705 phosphorylation within GFP + cells after incubation with IL-22, indicating functional IL-22R signalling in ISCs (Fig. 4b, c ). STAT3 phosphorylation was a specific response, as there was no effect of IL-22 on pSTAT1 in Lgr5 + cells ( Fig. 4c ).
IL-22R expression and STAT3 phosphorylation suggested that IL-22 might promote regeneration via direct targeting of ISCs. To investigate the role of ISCs and Paneth cells in IL-22-mediated regeneration further, we assessed organoid growth when either cell population was depleted. Treatment of transgenic mice expressing the diphtheria toxin receptor (Lgr5-DTR) with diphtheria toxin leads to a rapid deletion of Lgr5 + cells 25 . Deletion of Lgr5 + cells ex vivo by culturing Lgr5-DTR SI organoids with diphtheria toxin impaired epithelial regeneration as evidenced by a reduction in organoid size and efficiency ( Fig. 4d and Extended Data Fig. 9a ). Although IL-22 increased the size of Lgr5-DTR organoids cultured without diphtheria toxin, IL-22 failed to increase the size or maintain the numbers of Lgr5-DTR organoids cultured with diphtheria toxin ( Fig. 4d and Extended Data Fig. 9a ), indicating that Lgr5 + cells are essential for IL-22-mediated epithelial regeneration.
We next investigated the functional importance of Paneth cells for IL-22-mediated regeneration by culturing organoids with IL-22 after inducible Paneth cell depletion. Paneth cells were deleted in vivo after tamoxifen treatment of Atoh1 fl/fl ;Villin-Cre ERT2 (Atoh1 ΔIEC ) mice 26 . IL-22 led to robust STAT3 phosphorylation within Atoh1 ΔIEC SI organoids, confirming that Paneth cells were not essential for IL-22mediated intracellular signalling, and Atoh1 ΔIEC organoids demonstrated an intact growth response to IL-22 (Fig. 4e , f and Extended Data Fig. 9b ). Additionally, we found that IL-22 could augment the size of organoids cultured without EGF (Extended Data Fig. 9c, d) . These findings indicated that the Paneth cell niche was not required for IL-22-mediated epithelial regeneration, and IL-22 could promote the growth of organoids cultured without addition of the nichederived growth factor EGF.
Recent reports have suggested that T-cell-derived IL-22 may contribute to GVHD, as might peri-transplant administration of IL-22 to MHC-mismatched BMT recipients 27, 28 . However, IL-22-producing ILCs are eliminated in GVHD 19 , ILC deficiency is associated with increased clinical GVHD 29 , and gastrointestinal damage may be central to the pathogenesis of systemic GVHD 30 . We thus proposed that stimulating regeneration with IL-22 after the initiation of GVHD-related tissue damage may be therapeutically beneficial. Given the improved pharmacological stability of Fc-fusion molecules, we evaluated the potential of F-652, a rhIL-22-dimer and Fc-fusion protein, for treatment of systemic GVHD. First, we found that F-652 had activity in mouse epithelial regeneration, augmenting the growth of both small and large intestine organoids without evidence of toxicity (Extended Data Fig. 10a-d) . Second, treatment of Lgr5-LacZ reporter mice with F-652 significantly protected SI Lgr5 + crypt cells from radiation injury in vivo (Extended Data Fig. 10e , f). We next investigated an early intervention model for GVHD, treating allogeneic BMT recipients (LP into B6) with F-652 starting 1 week after transplantation. Mice treated with F-652 demonstrated reduced systemic signs of GVHD and GVHDrelated mortality compared to PBS-treated controls (Fig. 4g, h) .
In summary, we found that IL-22 links immunity to epithelial regeneration by acting directly on ISCs. Purified ILCs enhanced organoid 
growth in an IL-22-dependent fashion, and IL-22 augmented ISCmediated epithelial regeneration, promoting cell cycle progression, epithelial proliferation and regeneration of the ISC pool. IL-22 induced STAT3 phosphorylation in Lgr5 + ISCs, and while IL-22 may not be its sole regulator in ISCs, STAT3 was essential for organoid growth and IL-22-dependent epithelial regeneration. Paneth cells, in contrast, were not required for IL-22-driven regeneration. Given the activation of IL-22 production and the upregulation of crypt IL-22R expression after tissue damage, these findings indicate that IL-22 contributes to damage-induced regulation of the ISC compartment. We conclude that in addition to the stromal and epithelial components of the ISC niche that are essential for normal epithelial maintenance, IL-22 provides evidence for an immunological contribution to the ISC niche that is activated to restore the epithelium after tissue injury. By acting directly on epithelial stem cells, the immune system is thus able to regulate intestinal regeneration and support the fundamental defence system provided by the integrity of the epithelial barrier.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper.

METHODS
Mice. C57BL/6 (B6, H-2 b ) and LP (H-2 b ) mice were obtained from Jackson Laboratory. B6 Lgr5-LacZ and B6 lgr5-gfp-ires-CreERT2 (Lgr5-GFP) mice were provided by H. Clevers 1, 10 . Mouse maintenance and procedures were done in accordance with the institutional protocol guideline of the Memorial Sloan Kettering Cancer Center (MSKCC) Institutional Animal Care and Use Committee. Mice were housed in micro-isolator cages, five per cage, in MSKCC pathogen-free facilities, and received standard chow and autoclaved sterile drinking water. To adjust for differences in weight and intestinal flora among other factors, identical mice were purchased from Jackson and then randomly distributed over different cages and groups by a non-biased technician who had no insight or information about the purpose or details of the experiment. The investigations assessing clinical outcome parameters were performed by non-biased technicians with no particular knowledge or information regarding the hypotheses of the experiments and no knowledge of the specifics of the individual groups. Crypt isolation and cell dissociation. Isolation of intestinal crypts and the dissociation of cells for flow cytometry analysis were largely performed as previously described 10 . In brief, after euthanizing the mice with CO 2 and collecting small and large intestines, the organs were opened longitudinally and washed with PBS. To dissociate the crypts, small intestine was incubated at 4 °C in EDTA (10 mM) for 15 min and then in EDTA (5 mM) for an additional 15 min. Large intestine was incubated in collagenase type 4 (Worthington) for 30 min at 37 °C to isolate the crypts. To isolate single cells from small and large intestine crypts, the pellet was further incubated in 1× TrypLE express (Gibco, Life Technologies) supplemented with 0.8 kU ml −1 DNase1 (Roche). Organoid culture. For mouse organoids, depending on the experiments, 200-400 crypts per well were suspended in Matrigel composed of 25% advanced DMEM/ F12 medium (Gibco) and 75% growth-factor-reduced Matrigel (Corning). After the Matrigel polymerized, complete ENR medium containing advanced DMEM/ F12 (Sigma), 2 mM Glutamax (Invitrogen), 10 mM HEPES (Sigma), 100 U ml −1 penicillin, 100 μg ml −1 streptomycin (Sigma), 1 mM N-acetyl cysteine (Sigma), B27 supplement (Invitrogen), N2 supplement (Invitrogen), 50 ng ml −1 mouse EGF (Peprotech), 100 ng ml −1 mouse Noggin (Peprotech) and 10% human R-spondin-1-conditioned medium from R-spondin-1-transfected HEK 293T cells 31 was added to small intestine crypt cultures 10 . For experiments evaluating organoid budding, the concentration of R-spondin-1 was lowered to 1.25-5%. For mouse large intestine, crypts were cultured in 'WENR' medium containing 50% WNT3a-conditioned medium in addition to the aforementioned proteins and 1% BSA (Sigma), and supplemented with SB202190 (10 μM, Sigma), ALK5 inhibitor A83-01 (500 nM, Tocris Bioscience) and nicotinamide (10 mM, Sigma). Media was replaced every 2-3 days. Along with medium changes, treatment wells received different concentrations of rmIL-22 (Genscript). We also tested the effects of F-652 (Generon Corporation). In some experiments, organoids from crypts were cultured in the presence of Stattic (Tocris Bioscience). For passaging of organoids, after 5-7 days of culture, organoids were passaged by mechanically disrupting with a seropipet and cold media to depolymerize the Matrigel and generate organoid fragments. After washing away the old Matrigel by spinning down at 600 r.p.m., organoid fragments were replated in liquid Matrigel.
ISCs were isolated from Lgr5-GFP mice using a modified crypt isolation protocol with 20 min of 30 mM EDTA 32,33 followed by several strainer steps and a 5-min incubation with TrypLE and 0.8 kU ml −1 DNase1 under minute-to-minute vortexing to make a single-cell suspension. The Lgr5-GFP high cells were isolated by FACS. Approximately 5,000 ISCs were plated in 30 μl Matrigel and cultured in WENR media containing Rho-kinase/ROCK inhibitor Y-27632 (10 μM, Tocris Bioscience) and Jagged1 (1 μM, Anaspec). Starting from day 4, ISC were cultured without Wnt.
For lymphocyte co-culture experiments, ILCs were isolated from the small intestine lamina propria. Washed small intestine fragments were incubated in EDTA/IEL solution (1× PBS with 5% FBS, 10 mM HEPES buffer, 1% penicillin/ streptomycin (Corning), 1% l-glutamine (Gibco), 1 mM EDTA and 1 mM dithiothreitol (DTT)) in a 37 °C shaker for 15 min. The samples were strained (100 μM) and put in a Collagenase solution (RPMI 1640, 5% FCS, 10 mM HEPES, 1% penicillin/ streptomycin, 1% glutamine, 1 mg ml −1 collagenase D (Roche) and 1 U ml −1 DNase1 (Roche) and incubated twice for 10 min in a 37 °C shaker. Afterwards, the samples were centrifuged at 1,500 r.p.m. for 5 min and washed with RPMI solution without enzymes. After several washes, the cell suspension was transferred into a 40% Percoll solution (in PBS), which is overlaid on an 80% Percoll solution. After spinning the interface containing the lamina propria, mononuclear cells was aspirated and washed in medium. The cell suspension was then stained with extracellular markers and Topro3 for viability. Topro3 − CD45 + CD11b − CD11c − CD90 + LPLs from B6 wild-type and Il22 −/− mice and Topro3 − CD45 + CD3 − RORγt + ILC3s 34 from Rorc(γt)-GFP + mice (Jackson) were sorted for co-cultures with SI crypts.
(For antibodies used, see Supplementary Table 1 .) To activate and maintain LPLs and ILCs in culture, rmIL-2 (1,000 U ml −1 ), rmIL-15 (10 ng ml −1 ), rmIL-7 (50 ng ml −1 ) and rmIL-23 (50 ng ml −1 ) were added to the ENR medium in coculture experiments. We have also performed co-cultures with addition of only rmIL-23 (50 ng ml −1 ) to ENR media. LPLs and SI crypts were cultured in Matrigel with a 7:1 LPL:crypt ratio; ILCs and crypts were cultured in Matrigel with a 25:1 ILC:crypt ratio. Co-cultures were compared to crypts cultured in ENR plus cytokines without LPLs or ILCs present. A neutralizing monoclonal antibody against IL-22 (8E11, Genentech) 35 was used to abrogate IL-22-specific effects of ILCs.
For specific experiments, organoids were cultured from fresh crypts obtained from specific genetically modified mice, such as the Stat1 −/− mice (129S6/SvEv-Stat1tm1Rds, Taconic) and Stat3 fl/fl mice (Jackson). Organoids from Stat3 fl/fl mice that had been grown for 7 days were dissociated as single cells and incubated with adenoviral-Cre (University of Iowa) to cause the deletion of Stat3 from floxed organoid cells. Frozen passaged organoids from Lgr5 DTR (Lgr5-DTR) 25 mice were used to culture organoids in which Lgr5 + stem cells could be depleted with daily administration of diphtheria toxin (1 ng μl −1 ) .
For Paneth-cell-deficient organoid cultures, frozen crypts from Atoh1 ΔIEC mice 36 depleted of Paneth cells were used to culture organoids. As previously described 36 , Atoh1 ΔIEC mice (and littermate controls) were given an intraperitoneal injection of tamoxifen (1 mg per mouse, Sigma, dissolved in corn oil) for 5 consecutive days to achieve deletion of ATOH1 from intestinal epithelium. Animals were euthanized on day 7 after the first injection, and intestinal crypts were isolated and frozen in 10% dimethylsulfoxide (DMSO) and 90% FBS.
To investigate the effect of IL-22 on human small intestine, we generated human duodenal organoids from banked frozen organoids (>passage 7) that had been previously generated from biopsies obtained during duodenoscopy of three independent healthy human donors. All human donors had been investigated for coeliac disease, but turned out to have normal pathology. All provided written informed consent to participate in this study according to a protocol reviewed and approved by the review board of the UMC Utrecht, The Netherlands (protocol STEM study, METC 10-402/K). Human organoids were cultured in 10 μl Matrigel drops in expansion medium containing WENR with 10 nM SB202190, 500 nM A83-01 and 10 mM nicotinamide. For IL-22 stimulation experiments, rhIL-22 10 ng ml −1 (Genscript) was added daily. For the purpose of size measurements at day 6, organoids were passaged as single cells.
Where applicable, organoid cultures were performed using conditioned media containing R-spondin-1 and WNT3a produced by stably transfected cell lines. R-spondin-1-transfected HEK293T cells 31 were provided by C. Kuo. WNT3a-transfected HEK293T cells were provided by H. Clevers (patent WO2010090513A2). Cell lines were tested for mycoplasma and confirmed to be negative. Organoid measurement. For size evaluation, the surface area of organoid horizontal cross sections was measured. If all organoids in a well could not be measured, several random non-overlapping pictures were acquired from each well using a Zeiss Axio Observer Z1 inverted microscope and then analysed using MetaMorph or ImageJ software. Organoid perimeters for area measurements have been defined manually and by automated determination using the Analyze Particle function of ImageJ software, with investigator verification of the automated determinations, as automated measurements allowed for unbiased analyses of increased numbers of organoids. For automated size measurements, the threshold for organoid identification was set based on monochrome images. The sizes of the largest and smallest organoids in the reference well were measured manually, and their areas were used as the reference values for setting the minimal and maximal particle sizes. Organoids touching the edge of the images were excluded from the counting. After 5-7 days in culture, total organoid numbers per well were counted by light microscopy to evaluate growth efficiency. All organoid numbers were counted manually in this fashion except for the organoid counts presented in Extended Data Fig. 5b , which were counted using automated ImageJ analysis, as these organoids were too numerous to count manually. To compare organoid efficiency in different conditions, combining experiments with different organoid numbers, the percentage of organoids relative to the number of organoids in ENR-control (rmIL-22 0 ng ml −1 ) was calculated. The efficiency from sorted ISCs was presented as the percentage of cells forming organoids per number of seeded cells. BMT. BMT procedures were performed as previously described 37 . A minor histocompatibility antigen-mismatched BMT model (LP into B6; H-2 b into H-2 b ) was used. Female B6 wild-type mice were typically used as recipients for transplantation at an age of 8-10 weeks. Recipient mice received 1,100 cGy of split-dosed lethal irradiation (550 cGy × 2) 3-4 h apart to reduce gastrointestinal toxicity. To obtain LP bone marrow cells from euthanized donor mice, the femurs and tibias were collected aseptically and the bone marrow canals washed out with sterile media. Bone marrow cells were depleted of T cells by incubation with LETTER RESEARCH anti-Thy 1.2 and low-TOX-M rabbit complement (Cedarlane Laboratories). The TCD bone marrow was analysed for purity by quantification of the remaining T cell contamination using flow cytometry. T cell contamination was usually about 0.2% of all leukocytes after a single round of complement depletion. LP donor T cells were prepared by collecting splenocytes aseptically from euthanized donor mice. T cells were purified using positive selection with CD5 magnetic Microbeads with the MACS system (Miltenyi Biotec). T cell purity was determined by flow cytometry, and was routinely approximately 90%. Recipients typically received 5 × 10 6 TCD bone marrow cells with or without 4 × 10 6 T cells per mouse via tail vein injection.
Mice were monitored daily for survival and weekly for GVHD scores with an established clinical GVHD scoring system (including weight, posture, activity, fur ruffling and skin integrity) as previously described 38 . A clinical GVHD index with a maximum possible score of ten was then generated. Mice with a score of five or greater were considered moribund and euthanized by CO 2 asphyxia. In vivo cytokine administration. Recombinant mouse IL-22 was purchased from GenScript and reconstituted as described by the manufacturer to a concentration of 40 μg ml −1 in PBS. Mice were treated daily via i.p. injection with either 100 μl PBS or 100 μl PBS containing 4 μg rmIL-22. IL-22 administration was started on day 7 after BMT. This schedule was based on the results of rmIL-22 pharmacokinetics tested in untransplanted mice. For in vivo F-652 administration, starting from day 7 after BMT, mice were injected subcutaneously every other day for ten consecutive weeks with PBS or 100 μg kg −1 F-652. Histopathology analysis of GVHD target organs. Mice were euthanized for organ analysis 21 days after BMT using CO 2 asphyxiation. For histopathological analysis of GVHD, the small and large intestines were formalin-preserved, paraffinembedded, sectioned and stained with haematoxylin and eosin. An expert in the field of GVHD pathology, blinded to allocation, assessed the sections for markers of GVHD histopathology. As described previously 38 , a semiquantitative score consisting of 19 different parameters associated with GVHD was calculated. LacZ staining. For evaluation of stem-cell numbers, small intestines from Lgr5-LacZ recipient mice that were transplanted with LP bone marrow (and T cells where applicable) were collected. β-galactosidase (LacZ) staining was performed as previously described previously 1 . Washed 2.5-cm-sized small intestine fragments were incubated with an ice-cold fixative, consisting of 1% formaldehyde, 0.2% NP40 and 0.2% gluteraldehyde. After removing the fixative, organs were stained for the presence of LacZ according to manufacturer's protocol (LacZ staining kit, Invivogen). The organs were then formalin-preserved, paraffin-embedded, sectioned and counterstained with Nuclear Fast Red (Vector Labs). Immunohistochemistry staining. Immunohistochemistry detection of REG3β was performed at the Molecular Cytology Core Facility of MSKCC using a Discovery XT processor (Ventana Medical Systems). Formalin-fixed tissue sections were deparaffinized with EZPrep buffer (Ventana Medical Systems), antigen retrieval was performed with CC1 buffer (Ventana Medical Systems) and sections were blocked for 30 min with Background Buster solution (Innovex). Slides were incubated with anti-REG3β antibodies (R&D Systems, MAB5110; 1 μg ml −1 ) or isotype (5 μg ml −1 ) for 6 h, followed by a 60-min incubation with biotinylated goat anti-rat IgG (Vector Laboratories, PK-4004) at a 1:200 dilution. The detection was performed with a DAB detection kit (Ventana Medical Systems) according to the manufacturer's instructions. Slides were counterstained with haematoxylin (Ventana Medical Systems), and coverslips were added with Permount (Fisher Scientific). See Supplementary Table 1 for full description of antibodies used. Immunofluorescent staining and microscopic imaging. Immunofluorescent staining was performed at the Molecular Cytology Core Facility of Memorial Sloan Kettering Cancer Center using a Discovery XT processor (Ventana Medical Systems). Formalin-fixed tissue sections were deparaffinized with EZPrep buffer (Ventana Medical Systems), and antigen retrieval was performed with CC1 buffer (Ventana Medical Systems). Sections were blocked for 30 min with Background Buster solution (Innovex) followed by avidin/biotin blocking for 12 min. IL-22R antibodies (R&D Systems, MAB42; 0.1 μg ml −1 ) were applied and sections were incubated for 5 h followed by 60 min incubation with biotinylated goat anti-rat IgG (Vector Laboratories, PK-4004) at a 1:200 dilution. The detection was performed with streptavidin-horseradish peroxidase (HRP) D (part of DABMap kit, Ventana Medical Systems), followed by incubation with Tyramide Alexa Fluor 488 (Invitrogen, T20932) prepared according to manufacturer's instruction with predetermined dilutions. Next, lysozyme antibodies (DAKO, A099; 2 μg ml −1 ) were applied and sections were incubated for 6 h followed by incubation with biotinylated goat anti-rabbit IgG (Vector Laboratories, PK6101) for 60 min. The detection was performed with streptavidin-HRP D (part of DABMap kit, Ventana Medical Systems), followed by incubation with Tyramide Alexa Fluor 594 (Invitrogen, T20935) prepared according to manufacturer's instruction with predetermined dilutions. Finally, GFP antibodies were applied and sections were incubated for 5 h followed by incubation with biotinylated goat anti-chicken IgG (Vector Laboratories, BA-9010) for 60 min. The detection was performed with streptavidin-HRP D (part of DABMap kit, Ventana Medical Systems), followed by incubation with Tyramide Alexa Fluor 647 (Invitrogen, T20936) prepared according to manufacturer instruction with predetermined dilutions. Slides were counterstained with DAPI (Sigma Aldrich, D9542; 5 μg ml −1 ) for 10 min and coverslips were added with Mowiol. For immunofluorescent and other microscopic imaging, including LacZ and immunohistochemistry slides, contrast and white balance were set based on control slides for each experiment, and the same settings were used for all slides to maximize sharpness and contrast. See Supplementary Table 1 for full description of antibodies used. Cytokine multiplex assay. Spleen and small intestine were collected from euthanized BMT recipients, and organs were then homogenized and spun down. The supernatant was stored at −20 °C until use for cytokine analysis. The cytokine multiplex assays were performed on thawed samples with the mouse Th1/Th2/Th17/ Th22 13plex (FlowCytomix Multiplex kit, eBioscience) and performed according to the manufacturer's protocol. Flow cytometry. For in vivo experiments, lymphoid organs were collected from euthanized mice and processed into single cell suspension. Cells were stained with the appropriate mixture of antibodies. For intracellular analysis, an eBioscience Fixation/Permeabilization kit was used per the manufacturer's protocol. After thorough washing, the cells were stained with intracellular and extracellular antibodies simultaneously. Fluorochrome-labelled antibodies were purchased from BD Pharmingen (CD4, CD8, CD24, CD25, CD45, α4β7 and P-STAT3 Y705, P-STAT1 Y701), eBioscience (FOXP3), R&D (IL-22R), and Invitrogen (GFP). DAPI and Fixable Live/Dead Cell Stain Kits (Invitrogen) were used for viability staining. Paneth cells were identified based on bright CD24 staining and side scatter granularity as described previously 2 .
For flow cytometry of small intestine organoid cells, organoids were dissociated using TrypLE (37 °C). After vigorously pipetting through a p200 pipette causing mechanical disruption, the crypt suspension was washed with 10 ml of DMEM/ F12 medium containing 10% FBS and 0.8 kU ml −1 DNase1 and passaged through a cell strainer. Where applicable, the cells were directly stained or first fixed (4% paraformaldehyde) and permeabilized (methanol) depending on the extracellular or intracellular location of the target protein. All stainings with live cells were performed in PBS without Mg 2+ and Ca 2+ with 0.5% BSA. For EdU incorporation experiments there was a 1 h pre-incubation of EdU in the ENR medium of the intact organoid cultures before dissociating the cells with TrypLE. Cells were stained using Click-it kits for imaging and flow cytometry (Life Technologies). For cell cycle analysis, single cell suspensions obtained from dissociated organoids were fixed and stained with Hoechst 33342 (Life Technologies), then assessed with flow cytometry for DNA content and ploidy.
For intracellular pSTAT staining of organoids, organoids were mechanically disrupted into crypt fragments, stimulated for 20 min with 20 ng ml −1 IL-22 at 37 °C, and then fixed with 4% paraformaldehyde (10 min at 37 °C). To assess STAT activation in Lgr5 + cells, after freshly isolating crypts from Lgr5-GFP mice, single-cell suspensions including Y-27632 (10 μM) were stimulated with IL-22. After obtaining a single cell suspension of stimulated and fixed cells, the samples were filtered (40 μM) and permeabilized with ice-cold (−20 °C) methanol. Fixed and permeabilized cells were rehydrated with PBS and thoroughly washed with PBS before staining, then stained with anti-phospho-STAT3 and anti-phospho-STAT1, plus anti-GFP or cell surface markers, for 30 min at 4 °C.
All flow cytometry was performed with an LSRII cytometer (BD Biosciences) using FACSDiva (BD Biosciences), and the data were analysed with FlowJo software (Treestar). See Supplementary Table 1 for full description of antibodies used. Immunoblotting analysis. Western blot analysis was carried out on total protein extracts. Free-floating crypts isolated from small intestine were treated in DMEM supplemented with Y-27632 (10 ng ml −1 , Tocris) and IL-22 (5 ng ml −1 , 30 min). Vehicle (PBS) was added to control wells. Crypts were then lysed in RIPA buffer containing a cocktail of protease and phosphatase inhibitors (Sigma). After sonication, protein amount was determined using the bicinchoninic acid assay Kit (Pierce). Loading 30 μg per lane of lysate, proteins were separated using electrophoresis in a 10% polyacrylamide gel and transferred to nitrocellulose. Membranes were blocked for 1 h at room temperature with 1% Blot-Qualified BSA (Promega, W384A) and 1% non-fat milk (LabScientific, M0841) and then incubated overnight at 4 °C with the following primary antibodies: rabbit anti-phospho-STAT1 (7649P), rabbit anti-phospho-STAT3 (9131S), rabbit anti-STAT1 (9172P) and rabbit anti-STAT3 (4904P), all from Cell Signaling. This was followed by incubation with the secondary antibody anti-rabbit HRP (7074P2) and visualization with the Pierce ECL Western Blotting Substrate (Thermo Scientific, 32106). MTT assay. Cell viability in organoids was assessed with a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium (MTT) test, based on the identification of LETTER RESEARCH 
